Targeting Kinases in Cancer Therapies: Adverse Effects on Blood Platelets

E-ISSN： 1873-4286|22|16|2315-2322

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.16, 2016-05, pp. : 2315-2322

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Aurora kinases in ovarian cancer

By Fu Siqing Hu Wei Kavanagh John J Bast Jr Robert C

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 1, 2006-02 ,pp. : 77-85

Informa Healthcare

Access to resources Recommend Favorite

Targeting tyrosine-kinases in ovarian cancer

By Morotti Matteo Becker Christian M Menada Mario Valenzano Ferrero Simone

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 10, 2013-10 ,pp. : 1265-1279

Informa Healthcare

Access to resources Recommend Favorite

Targeting Aurora Kinases in Cancer Treatment

Current Drug Targets, Vol. 12, Iss. 14, 2011-12 ,pp. : 2067-2078

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic targeting of receptor tyrosine kinases in lung cancer

By Choong Nicholas W Ma Patrick C Salgia Ravi

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 533-559

Informa Healthcare

Access to resources Recommend Favorite

Targeting Cell Cycle Kinases for Cancer Therapy

Current Medicinal Chemistry, Vol. 14, Iss. 9, 2007-04 ,pp. : 969-985

Bentham Science Publishers

Access to resources Recommend Favorite